Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Psychemedics
(NQ:
PMD
)
2.345
+0.010 (+0.43%)
Streaming Delayed Price
Updated: 3:55 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Psychemedics
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
September 26, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Launches New Ketamine Hair Testing Service
August 29, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
August 13, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock
August 12, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
June 21, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Reports First Quarter 2024 Financial Results
May 14, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Reports 2023 Financial Results
March 28, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
March 21, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
January 02, 2024
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
November 27, 2023
From
Psychemedics Corporation
Via
GlobeNewswire
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
October 27, 2023
Psychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl.
From
Psychemedics Corporation
Via
GlobeNewswire
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
September 21, 2023
From
Psychemedics Corporation
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.